Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-19

FDA Approved: INNOPRAN XL — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' supplemental application for INNOPRAN XL (propranolol hydrochloride). The approval confirms changes to the product's labeling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INNOPRAN XL (PROPRANOLOL HYDROCHLORIDE)

Snippet

SUPPL AP for INNOPRAN XL (PROPRANOLOL HYDROCHLORIDE)